Finch Therapeutics Group Inc

FNCH•United States

Healthcare United States Biological Products

Need professional-grade analysis? Visit stockanalysis.com

$12.00

-6.25%

End of day

Market Cap

N/A

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	—	-1.33	-0.15	-0.58	—	-0.62
Calmar	—	—	-1.97	-0.19	-0.81	—	-0.89
Sharpe	—	—	-1.11	-0.10	-0.38	—	-0.47
Omega	—	—	0.72	1.01	0.95	—	0.91
Martin	—	—	-5.44	-0.54	-1.45	—	-2.14
Ulcer	—	—	6.03	6.05	9.86	—	7.63

Finch Therapeutics Group Inc (FNCH) Price Performance

Finch Therapeutics Group Inc (FNCH) trades on United States in USD. The company is classified in the Healthcare sector under the Biological Products industry. The stock currently trades at $12.00, down 6.25% from the previous close.

Over the past year, FNCH has traded between a low of $12.00 and a high of $14.56. The stock has lost 14.3% over this period. It is currently 17.6% below its 52-week high.

Company Info

Sector: Healthcare
Industry: Biological Products
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): $107,000
EBITDA: N/A
Profit Margin: -69863.55%
EPS (TTM): N/A
Book Value: 22.89

Technical Indicators

52 Week High: $16.10
52 Week Low: $11.50
50 Day MA: $13.54
200 Day MA: $13.13
Beta: N/A

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: N/A
Enterprise Value: N/A